The latest gynaecological cancer news
Novel molecule disrupts ovarian and breast cancer growth in animal models
Researchers at Baylor College of Medicine have identified a small molecule named 5D4 that can…
Browsing: Gynaecologic Cancers
ESMO 2023: Advances in gynaecological cancer research could change the treatment landscape
Results from highly anticipated phase 3 clinical trials in gynaecological cancers with, among others, new…
ESMO 2023: Better use of existing drugs increases cervical cancer survival and reduces recurrence
The INTERLACE phase III trial, funded by Cancer Research UK and UCL Cancer Trials Centre,…
Researchers develop blood test for early-stage ovarian cancer
High-grade serous ovarian carcinoma (HGSOC) is the most common type of ovarian cancer. It is…
Four novel receptors may link endometrial cancer to PCOS
A new research paper was published in Oncotarget’s Volume 14 on September 22, 2023, entitled, “Transcriptomic analysis identifies…
The silence around vulval cancer means people are missing the signs that they have it
Sophie Rees, University of Bristol Most people have heard of cervical, ovarian, and perhaps womb…
ASTRO 2023: Sexual activity and vaginal dilation associated with fewer side effects after cervical cancer treatment
People who engage in sexual activity or vaginal dilation after chemoradiation treatment for cervical cancer…
Study finds significant chemical exposures in women with cancer
In a sign that exposure to certain endocrine-disrupting chemicals may be playing a role in…
Combination of cancer vaccine and T cell therapy benefits patients with advanced ovarian cancer
A Ludwig Cancer Research study has shown that combining adoptive T cell therapy (ACT) with…
Ovarian cancer is not ovarian cancer
Dr Ian Nisbet and Kathy Skoff recently attended an ovarian cancer symposium in Sydney, organised…